|
1
|
Jemal A, Siegel R, Ward E, et al: Cancer
statistics, 2008. CA Cancer J Clin. 58:71–96. 2008. View Article : Google Scholar
|
|
2
|
Jemal A, Siegel R, Ward E, Hao Y, Xu J and
Thun MJ: Cancer statistics, 2009. CA Cancer J Clin. 59:225–249.
2009. View Article : Google Scholar
|
|
3
|
Jemal A, Siegel R, Xu J and Ward E: Cancer
statistics, 2010. CA Cancer J Clin. 60:277–300. 2010. View Article : Google Scholar
|
|
4
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar
|
|
5
|
Lanier LL: NK cell receptors. Annu Rev
Immunol. 16:359–393. 1998. View Article : Google Scholar
|
|
6
|
Bauer S, Groh V, Wu J, et al: Activation
of NK cells and T cells by NKG2D, a receptor for stress-inducible
MICA. Science. 285:727–729. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Eleme K, Taner SB, Onfelt B, et al: Cell
surface organization of stress-inducible proteins ULBP and MICA
that stimulate human NK cells and T cells via NKG2D. J Exp Med.
199:1005–1010. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ota T, Takeda K, Akiba H, et al:
IFN-gamma-mediated negative feedback regulation of NKT-cell
function by CD94/NKG2. Blood. 106:184–192. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sheu BC, Chiou SH, Lin HH, et al:
Up-regulation of inhibitory natural killer receptors CD94/NKG2A
with suppressed intracellular perforin expression of
tumor-infiltrating CD8+ T lymphocytes in human cervical
carcinoma. Cancer Res. 65:2921–2929. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lanier LL: Follow the leader: NK cell
receptors for classical and nonclassical MHC class I. Cell.
92:705–707. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Groh V, Rhinehart R, Secrist H, Bauer S,
Grabstein KH and Spies T: Broad tumor-associated expression and
recognition by tumor-derived gamma delta T cells of MICA and MICB.
Proc Natl Acad Sci USA. 96:6879–6884. 1999. View Article : Google Scholar
|
|
12
|
Wu J, Song Y, Bakker AB, et al: An
activating immunoreceptor complex formed by NKG2D and DAP10.
Science. 285:730–732. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yamamoto K, Fujiyama Y, Andoh A, Bamba T
and Okabe H: Oxidative stress increases MICA and MICB gene
expression in the human colon carcinoma cell line (CaCo-2). Biochim
Biophys Acta. 1526:10–12. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Gasser S, Orsulic S, Brown EJ and Raulet
DH: The DNA damage pathway regulates innate immune system ligands
of the NKG2D receptor. Nature. 436:1186–1190. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Palmisano GL, Contardi E, Morabito A,
Gargaglione V, Ferrara GB and Pistillo MP: HLA-E surface expression
is independent of the availability of HLA class I signal
sequence-derived peptides in human tumor cell lines. Hum Immunol.
66:1–12. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Cao W, Xi X, Wang Z, et al: Four novel
ULBP splice variants are ligands for human NKG2D. Int Immunol.
20:981–991. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Guerra N, Tan YX, Joncker NT, et al:
NKG2D-deficient mice are defective in tumor surveillance in models
of spontaneous malignancy. Immunity. 28:571–580. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ljunggren HG: Cancer immunosurveillance:
NKG2D breaks cover. Immunity. 28:492–494. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Melum E, Buch S, Schafmayer C, et al:
Investigation of cholangiocarcinoma associated NKG2D polymorphisms
in colorectal carcinoma. Int J Cancer. 123:241–242. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Nausch N and Cerwenka A: NKG2D ligands in
tumor immunity. Oncogene. 27:5944–5958. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Barber A and Sentman CL: Chimeric NKG2D T
cells require both T cell-and host-derived cytokine secretion and
perforin expression to increase tumor antigen presentation and
systemic immunity. J Immunol. 183:2365–2372. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Berezhnoi AE, Chernisheva AD, Zakeeva IR,
et al: HLA-E molecule induction on the surface of tumor cells
protects them from cytotoxic lymphocytes. Vopr Onkol. 55:224–229.
2009.(In Russian).
|
|
23
|
Kopp R, Glas J, Lau-Werner U, Albert ED
and Weiss EH: Association of MICA-TM and MICB C1_2_A microsatellite
polymorphisms with tumor progression in patients with colorectal
cancer. J Clin Immunol. 29:545–554. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zeng XH, Sha WH, Li YY, Nie YQ, Li QN and
Liang PZ: Expression of NK cells receptor NKG2D from peripheral
blood in patients with primary hepatic carcinoma and its clinical
significance. Zhonghua Yi Xue Za Zhi. 89:1272–1274. 2009.(In
Chinese).
|
|
25
|
Bjorklund AT, Schaffer M, Fauriat C, et
al: NK cells expressing inhibitory KIR for non-self-ligands remain
tolerant in HLA-matched sibling stem cell transplantation. Blood.
115:2686–2694. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kren L, Slaby O, Muckova K, et al:
Expression of immune-modulatory molecules HLA-G and HLA-E by tumor
cells in glioblastomas: an unexpected prognostic significance?
Neuropathology. 31:129–134. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhang C, Zhang J, Sun R, Feng J, Wei H and
Tian Z: Opposing effect of IFNgamma and IFNalpha on expression of
NKG2 receptors: negative regulation of IFNgamma on NK cells. Int
Immunopharmacol. 5:1057–1067. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhang C, Zhang J, Niu J, Zhou Z and Tian
Z: Interleukin-12 improves cytotoxicity of natural killer cells via
upregulated expression of NKG2D. Hum Immunol. 69:490–500. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Serrano AE, Menares-Castillo E,
Garrido-Tapia M, et al: Interleukin 10 decreases MICA expression on
melanoma cell surface. Immunol Cell Biol. 89:447–457. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhang J, Sun R, Wei H and Tian Z:
Characterization of interleukin-15 gene-modified human natural
killer cells: implications for adoptive cellular immunotherapy.
Haematologica. 89:338–347. 2004.PubMed/NCBI
|
